U.S. Pharmaceuticals & Biotech Most Popular Stocks

Beleave

Market Cap: US$553.0

Operates as a medical cannabis company in Canada.

Mera Pharmaceuticals

Market Cap: US$536.0

Focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.

Instadose Pharma

Market Cap: US$531.0

Engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil.

Tetra Bio-Pharma

Market Cap: US$515.0

A biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology.

OWC Pharmaceutical Research

Market Cap: US$497.0

Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.

Abattis Bioceuticals

Market Cap: US$476.0

Operates as a life sciences and biotechnology company in Canada.

Flower One Holdings

Market Cap: US$473.0

Engages in the cultivation and production of medical and recreational cannabis.

Choom Holdings

Market Cap: US$466.0

Engages in the retail of cannabis.

Radiko Holdings

Market Cap: US$459.0

Focuses on cannabis industries in the United States and internationally.

Flowr

Market Cap: US$426.0

The Flowr Corporation cultivates, produces, and sells cannabis in Canada.

Cannabis Strategic Ventures

Market Cap: US$404.0

Engages in the cultivation of marijuana products in the United States.

Clever Leaves Holdings

Market Cap: US$350.0

Operates in the botanical cannabinoid and nutraceutical industries.

Nabriva Therapeutics

Market Cap: US$323.0

A biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections.

YourWay Cannabis Brands

Market Cap: US$272.0

Through its subsidiaries, engages in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis market in the United States.

Spencer Pharmaceutical

Market Cap: US$271.0

Develops drug platform technologies for the treatment of neurological deceases.

BZAM

Market Cap: US$270.0

Operates as a cannabis producer with a focus on branded consumer goods.

GeneLink

Market Cap: US$265.0

Offers 12-gene DNA assessment services.

Nanobac Pharmaceuticals

Market Cap: US$249.0

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs).

Green Growth Brands

Market Cap: US$238.0

Engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabidiol (CBD)-infused consumer products in the United States.

Wayland Group

Market Cap: US$237.0

Produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally.

Khiron Life Sciences

Market Cap: US$232.0

Operates as an integrated medical and cannabis company in Latin America and Europe.

BC Craft Supply

Market Cap: US$227.0

Engages in development and acquisition of nutritional product formulae and cannabinoid brands.

Seelos Therapeutics

Market Cap: US$217.0

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders.

Fiore Cannabis

Market Cap: US$197.0

Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States.

Isracann Biosciences

Market Cap: US$176.0

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel.

Lucy Scientific Discovery

Market Cap: US$176.0

An early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.

Pure Global Cannabis

Market Cap: US$163.0

Produces cannabis products for the medical and adult-use markets in Canada.

InNexus Biotechnology

Market Cap: US$154.0

A development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology.

Mymetics

Market Cap: US$151.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Immage Biotherapeutics

Market Cap: US$151.0

Does not have significant business operations.

Halo Collective

Market Cap: US$150.0

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Gritstone bio

Market Cap: US$147.0

A clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases.

CannTrust Holdings

Market Cap: US$141.0

Produces and distributes medical and recreational cannabis in Canada.

NexImmune

Market Cap: US$139.0

A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.

PsyBio Therapeutics

Market Cap: US$132.0

A biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.

Lattice Biologics

Market Cap: US$128.0

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.